Designation
.gif){kind=small}
Information about pandemic influenza vaccinesИнформация относно ваксини за пандемичен грипInformación sobre vacunas contra la pandemia gripal Informace o vakcínách proti pandemické chřipce Information om vacciner mod pandemisk influenza Informationen über Impfstoffe gegen pandemische Influenza Teave pandeemiliste gripivaktsiinide kohta Πληροφορίες για τα εμβόλια της πανδημικής γρίπης Informations sur les vaccins contre la grippe pandémiqueInformazioni sui vaccini per l’influenza pandemica Informācija par gripas pandēmijas vakcīnām Informacija apie vakcinas nuo pandeminio gripo Világméretű influenzajárvány elleni vakcinákra vonatkozó információk Informazzjoni dwar il-vaċċini għall-influwenza pandemika Informatie over vaccins tegen pandemische griep Informacje o szczepionkach przeciw grypie pandemicznej Informação sobre vacinas contra a pandemia da gripe Informaţii despre vaccinurile gripale pandemice Informácie o očkovacích látkach proti pandemickej chrípke Informacije o cepivih proti pandemični gripi Tietoa influenssapandemian aikana käytettävistä rokotteista Information om vacciner mot pandemisk influensa
|
| EMEA IT Systems Shutdown |
Published 13/11/2009 |
As part of its business continuity planning, the Agency's IT sector will be testing the recovery of all IT systems to the EMEA's disaster recovery data centre. During the exercise which will start on Friday, November 20 at 18:00 and will last until Monday, November 23, 8:00, the Agency's IT systems - including all of its websites - will become unavailable for a certain period of time. We apologize for any inconvenience this may cause. |
| European Medicines Agency reaffirms efficacy and safety of H1N1 pandemic vaccines |
Published 20/11/2009 |
The European Medicines Agency has reviewed further data on the centrally authorised pandemic vaccines, Celvapan, Focetria and Pandemrix. The Agency has reaffirmed their positive balance of benefits and risks in the context of the current H1N1 influenza pandemic. The Agency also recommended further changes to the product information to Focetria and Pandemrix. |
A more detailed Press Release is available here The English version of the revised Product Information adopted by the CHMP on 19 November 2009 is available for Focetria and Pandemrix. |
| 18 November 2009 is European Antibiotic Awareness Day |
Published 18/11/2009 |
The European Antibiotic Awareness Day provides an annual opportunity for raising awareness about the threat to public health of antibiotic resistance and about how to use antibiotics responsibly. This Awareness Day is initiated by the European Centre for Disease Prevention and Control (ECDC), with whom the European Medicines Agency has recently worked on two antimicrobial resistance related projects. The results of these projects emphasise the importance of the judicious use of antibiotics in the treatment of human and animal bacterial infections. |
Additional information on the Agency’s work on antimicrobial resistance in animals / Additional information on the Agency’s work on antimicrobial resistance in humans |
| European strategy for benefit-risk monitoring of influenza A/H1N1 vaccines adopted |
Published 05/11/2009 |
The European Medicines Agency, the European Centre for Disease Prevention and Control and the Heads of Medicines Agencies have adopted a strategy to further strengthen the coordination of benefit-risk monitoring for influenza A/H1N1 vaccines. |